John Chalmers Selected Research

perindopril drug combination indapamide

2/2022	Clinical outcomes by atherosclerotic cardiovascular disease risk score and blood pressure level in high risk individuals with type 2 diabetes.
1/2022	Effects of glucose and blood pressure reduction on subclinical cardiac damage: Results from ADVANCE.
3/2021	Economic Evaluation of a New Polygenic Risk Score to Predict Nephropathy in Adult Patients With Type 2 Diabetes.
1/2021	History of lower-limb complications and risk of cancer death in people with type 2 diabetes.
1/2021	The Impact of Frailty on the Effectiveness and Safety of Intensive Glucose Control and Blood Pressure-Lowering Therapy for People With Type 2 Diabetes: Results From the ADVANCE Trial.
1/2021	Sex differences in risk factors for cognitive decline and dementia, including death as a competing risk, in individuals with diabetes: Results from the ADVANCE trial.
12/2020	Alternative kidney filtration markers and the risk of major macrovascular and microvascular events, and all-cause mortality in individuals with type 2 diabetes in the ADVANCE trial.
1/2020	Plasma fatty acids and the risk of vascular disease and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE study.
1/2020	Effects of Intensive Glycemic Control on Clinical Outcomes Among Patients With Type 2 Diabetes With Different Levels of Cardiovascular Risk and Hemoglobin A1c in the ADVANCE Trial.
1/2020	The Risks of Cardiovascular Disease and Mortality Following Weight Change in Adults with Diabetes: Results from ADVANCE.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John Chalmers Research Topics

Disease

77	Type 2 Diabetes Mellitus (MODY) 02/2022 - 01/2003
71	Vascular Diseases (Vascular Disease) 02/2022 - 01/2003
71	Stroke (Strokes) 01/2022 - 05/2003
48	Hypertension (High Blood Pressure) 01/2022 - 05/2003
30	Ischemic Stroke 01/2022 - 09/2005
23	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2014 - 05/2003
17	Cerebral Hemorrhage 12/2022 - 02/2010
15	Cardiovascular Diseases (Cardiovascular Disease) 02/2022 - 09/2003
9	Myocardial Infarction 12/2022 - 09/2005
9	Heart Failure 01/2017 - 10/2004
8	Transient Ischemic Attack 11/2021 - 05/2003
8	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2021 - 01/2012
8	Atrial Fibrillation 01/2021 - 10/2005
8	Albuminuria 01/2019 - 05/2010
7	Diabetic Nephropathies (Diabetic Nephropathy) 03/2021 - 10/2004
7	Chronic Kidney Failure (Chronic Renal Failure) 01/2020 - 03/2013
7	Diabetes Mellitus 01/2020 - 03/2016
7	Hematoma 01/2019 - 07/2012
7	Coronary Disease (Coronary Heart Disease) 01/2018 - 10/2004
6	Cognitive Dysfunction 12/2022 - 05/2003
6	Diabetes Complications 10/2021 - 02/2010
6	Chronic Renal Insufficiency 07/2016 - 10/2004
5	Dementia (Dementias) 11/2021 - 05/2003
5	Hemorrhage 01/2019 - 06/2012
4	Neoplasms (Cancer) 01/2021 - 08/2012
4	Body Weight (Weight, Body) 01/2019 - 12/2015
4	Coronary Artery Disease (Coronary Atherosclerosis) 06/2017 - 08/2010
4	Peripheral Vascular Diseases (Peripheral Vascular Disease) 10/2014 - 10/2005
3	Renal Insufficiency (Renal Failure) 01/2022 - 03/2013
3	Kidney Diseases (Kidney Disease) 02/2021 - 05/2016
3	Hypoglycemia (Reactive Hypoglycemia) 01/2021 - 10/2010
2	Isolated Systolic Hypertension 12/2022 - 06/2009
2	Genetic Risk Score 10/2021 - 01/2021
2	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2021 - 01/2021
2	Atrophy 01/2019 - 03/2004
2	Blindness (Hysterical Blindness) 01/2016 - 01/2016
2	Proteinuria 07/2015 - 10/2008
2	Inflammation (Inflammations) 03/2014 - 08/2008
1	Syncope (Fainting) 12/2021

Drug/Important Bio-Agent (IBA)

63	Gliclazide (Diamicron)IBA 02/2022 - 01/2003
62	perindopril drug combination indapamideIBA 02/2022 - 01/2003
49	Perindopril FDA LinkGeneric 01/2022 - 05/2003
34	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 01/2003
32	Indapamide FDA LinkGeneric 12/2022 - 05/2003
29	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022 - 07/2015
16	Antihypertensive Agents (Antihypertensives)IBA 12/2022 - 05/2003
15	CreatinineIBA 01/2021 - 06/2011
13	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2021 - 01/2003
11	Pharmaceutical PreparationsIBA 12/2022 - 10/2004
11	DiureticsIBA 01/2020 - 01/2003
10	Biomarkers (Surrogate Marker)IBA 02/2021 - 03/2012
10	LipidsIBA 01/2021 - 09/2005
8	AlbuminsIBA 03/2021 - 10/2008
5	Blood Glucose (Blood Sugar)IBA 01/2022 - 03/2009
5	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 11/2021 - 06/2009
5	C-PeptideIBA 04/2021 - 01/2019
5	Insulin (Novolin)FDA Link 01/2021 - 05/2013
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 10/2005
5	HDL CholesterolIBA 01/2019 - 09/2005
5	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2017 - 01/2014
5	Troponin T (Troponin T1)IBA 01/2017 - 01/2014
5	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 03/2011 - 01/2003
3	Hemoglobins (Hemoglobin)IBA 01/2022 - 03/2009
3	Warfarin (Coumadin)FDA LinkGeneric 01/2021 - 01/2016
3	Retinaldehyde (Retinal)IBA 01/2017 - 01/2016
3	C-Reactive ProteinIBA 01/2017 - 08/2008
3	Interleukin-6 (Interleukin 6)IBA 01/2017 - 08/2008
3	pro-brain natriuretic peptide (1-76)IBA 01/2017 - 01/2014
3	SaltsIBA 04/2014 - 05/2013
3	Fibrinogen (Factor I)FDA Link 03/2014 - 10/2005
3	Phosphotransferases (Kinase)IBA 03/2014 - 04/2013
3	Biological ProductsIBA 11/2013 - 06/2011
2	Angiotensin Receptor AntagonistsIBA 11/2021 - 01/2021
2	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 11/2021 - 01/2021
2	CholesterolIBA 01/2021 - 09/2005
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2021 - 05/2016
2	P-2 (P 2)IBA 01/2021 - 05/2003
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 09/2010
2	cyclo(Arg-Pro) (CI 4)IBA 01/2016 - 02/2010
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 10/2014 - 06/2008
2	IsoenzymesIBA 03/2014 - 04/2013
2	antineoplaston A10 (A 10)IBA 01/2012 - 05/2010
1	Amlodipine (Norvasc)FDA LinkGeneric 12/2022
1	Telmisartan (Micardis)FDA Link 12/2022
1	Apolipoproteins E (ApoE)IBA 11/2021
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 02/2021
1	Type II Tumor Necrosis Factor ReceptorsIBA 02/2021
1	AutoantibodiesIBA 02/2021

Therapy/Procedure

47	Therapeutics 12/2022 - 05/2003
8	Glycemic Control 01/2020 - 06/2008
6	Secondary Prevention 12/2021 - 10/2004
6	Contraindications 01/2019 - 06/2006
3	Light Coagulation 01/2017 - 01/2016
3	Length of Stay 07/2014 - 02/2009
2	Critical Care (Surgical Intensive Care) 01/2021 - 01/2021
2	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2019 - 11/2012
2	Kidney Transplantation 05/2016 - 03/2013
2	Surgical Amputation (Amputations) 01/2016 - 01/2016
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 04/2013 - 03/2013
1	Transplantation 01/2022